Quanterix Corporation engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics.It offers HD-X instrument, a sensitive automated multiplex protein detection platform; SR-X and SP-X instruments. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation.
